TORONTO, April 28, 2025 /CNW/ - HLS Therapeutics Inc. (HLS or the Company) (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, announces that Brian Walsh, Chief Commercial Officer, will present at the 2025 Bloom Burton & Co. Healthcare Investor Conference, which takes place May 5-6, 2025 at the Metro Toronto Convention Centre, in downtown Toronto.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
HLS Therapeutics to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
